Immunize and disappear-Safety-optimized mRNA vaccination with a panel of 29 allergens

Journal of Allergy and Clinical Immunology

Volumn 124, Issue 5, 2009, Pages

  Roesler, Elisabeth ^a   Weiss, Richard ^a   Weinberger, Esther E ^a   Fruehwirth, Angelika ^a   Stoecklinger, Angelika ^a   Mostböck, Sven ^b   Ferreira, Fatima ^a   Thalhamer, Josef ^a   Scheiblhofer, Sandra ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

DNA vaccines; RNA vaccines; self replicating vaccines; type I allergy; vaccination

Indexed keywords

ALLERGEN; CD8 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; MESSENGER RNA VACCINE; RNA VACCINE; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BODY PLETHYSMOGRAPHY; CD8+ T LYMPHOCYTE; CELL CULTURE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL COUNT; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GRASS POLLEN; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RNA IMMUNIZATION; SENSITIZATION; SPLEEN CELL;

ALLERGENS; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; FEMALE; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INJECTIONS, INTRADERMAL; MICE; MICE, INBRED BALB C; RNA, MESSENGER; VACCINATION; VACCINES;

EID: 71749093911     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.06.036     Document Type: Article

References (34)

1. Bousquet P.J., Chinn S., Janson C., Kogevinas M., Burney P., and Jarvis D. Geographical variation in the prevalence of positive skin tests to environmental aeroallergens in the European Community Respiratory Health Survey I. Allergy 62 (2007) 301-309
2. Wuthrich B., Schindler C., Leuenberger P., and Ackermann-Liebrich U. Prevalence of atopy and pollinosis in the adult population of Switzerland (SAPALDIA study). Swiss Study on Air Pollution and Lung Diseases in Adults. Int Arch Allergy Immunol 106 (1995) 149-156
3. Ono S.J. Molecular genetics of allergic diseases. Annu Rev Immunol 18 (2000) 347-366
4. Shaheen S.O., Aaby P., Hall A.J., Barker D.J., Heyes C.B., Shiell A.W., et al. Measles and atopy in Guinea-Bissau. Lancet 347 (1996) 1792-1796
5. von Mutius E., Braun-Fahrlander C., Schierl R., Riedler J., Ehlermann S., Maisch S., et al. Exposure to endotoxin or other bacterial components might protect against the development of atopy. Clin Exp Allergy 30 (2000) 1230-1234
6. Ball T., Sperr W.R., Valent P., Lidholm J., Spitzauer S., Ebner C., et al. Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy. Eur J Immunol 29 (1999) 2026-2036
7. Van Ree R., Van Leeuwen W.A., Dieges P.H., Van Wijk R.G., De Jong N., Brewczyski P.Z., et al. Measurement of IgE antibodies against purified grass pollen allergens (Lol p 1, 2, 3 and 5) during immunotherapy. Clin Exp Allergy 27 (1997) 68-74
8. Radbruch A., Muehlinghaus G., Luger E.O., Inamine A., Smith K.G., Dorner T., et al. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol 6 (2006) 741-750
9. Weiss R., Scheiblhofer S., Gabler M., Ferreira F., Leitner W.W., and Thalhamer J. Is genetic vaccination against allergy possible?. Int Arch Allergy Immunol 139 (2006) 332-345
10. Medjitna T.D., Stadler C., Bruckner L., Griot C., and Ottiger H.P. DNA vaccines: safety aspect assessment and regulation. Dev Biol (Basel) 126 (2006) 261-270 327
11. Slater J.E., Paupore E., Zhang Y.T., and Colberg-Poley A.M. The latex allergen Hev b 5 transcript is widely distributed after subcutaneous injection in BALB/c mice of its DNA vaccine. J Allergy Clin Immunol 102 (1998) 469-475
12. Probst J., Weide B., Scheel B., Pichler B.J., Hoerr I., Rammensee H.G., et al. Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent. Gene Ther 14 (2007) 1175-1180
13. Ying H., Zaks T.Z., Wang R.F., Irvine K.R., Kammula U.S., Marincola F.M., et al. Cancer therapy using a self-replicating RNA vaccine. Nat Med 5 (1999) 823-827
14. Gabler M., Scheiblhofer S., Kern K., Leitner W.W., Stoecklinger A., Hauser-Kronberger C., et al. Immunization with a low-dose replicon DNA vaccine encoding Phl p 5 effectively prevents allergic sensitization. J Allergy Clin Immunol 118 (2006) 734-741
15. Hartl A., Weiss R., Hochreiter R., Scheiblhofer S., and Thalhamer J. DNA vaccines for allergy treatment. Methods 32 (2004) 328-339
16. Hochreiter R., Stepanoska T., Ferreira F., Valenta R., Vrtala S., Thalhamer J., et al. Prevention of allergen-specific IgE production and suppression of an established Th2-type response by immunization with DNA encoding hypoallergenic allergen derivatives of Bet v 1, the major birch-pollen allergen. Eur J Immunol 33 (2003) 1667-1676
17. Bauer R., Scheiblhofer S., Kern K., Gruber C., Stepanoska T., Thalhamer T., et al. Generation of hypoallergenic DNA vaccines by forced ubiquitination: preventive and therapeutic effects in a mouse model of allergy. J Allergy Clin Immunol 118 (2006) 269-276
18. Hamelmann E., Schwarze J., Takeda K., Oshiba A., Larsen G.L., Irvin C.G., et al. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 156 (1997) 766-775
19. Riedler J., Braun-Fahrlander C., Eder W., Schreuer M., Waser M., Maisch S., et al. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet 358 (2001) 1129-1133
20. Romagnani S. Immunologic influences on allergy and the TH1/TH2 balance. J Allergy Clin Immunol 113 (2004) 395-400
21. Scheiblhofer S., Gabler M., Leitner W.W., Bauer R., Zoegg T., Ferreira F., et al. Inhibition of type I allergic responses with nanogram doses of replicon-based DNA vaccines. Allergy 61 (2006) 828-835
22. Scheiblhofer S., Stoecklinger A., Gruber C., Hauser-Kronberger C., Alinger B., Hammerl P., et al. Gene gun immunization with clinically relevant allergens aggravates allergen induced pathology and is contraindicated for allergen immunotherapy. Mol Immunol 44 (2007) 1879-1887
23. Leitner W.W., Hwang L.N., Bergmann-Leitner E.S., Finkelstein S.E., Frank S., and Restifo N.P. Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines. Vaccine 22 (2004) 1537-1544
24. Pascolo S. Messenger RNA-based vaccines. Expert Opin Biol Ther 4 (2004) 1285-1294
25. Carralot J.P., Probst J., Hoerr I., Scheel B., Teufel R., Jung G., et al. Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines. Cell Mol Life Sci 61 (2004) 2418-2424
26. Khromykh A.A. Replicon-based vectors of positive strand RNA viruses. Curr Opin Mol Ther 2 (2000) 555-569
27. von Herrath M.G., and Bot A. Immune responsiveness, tolerance and dsRNA: implications for traditional paradigms. Trends Immunol 24 (2003) 289-293
28. Yamamoto S., Kobayashi I., Tsuji K., Nishi N., Muro E., Miyazaki M., et al. Upregulation of interleukin-4 receptor by interferon-gamma: enhanced interleukin-4-induced eotaxin-3 production in airway epithelium. Am J Respir Cell Mol Biol 31 (2004) 456-462
29. Ford J.G., Rennick D., Donaldson D.D., Venkayya R., McArthur C., Hansell E., et al. Il-13 and IFN-gamma: interactions in lung inflammation. J Immunol 167 (2001) 1769-1777
30. Finkelman F.D. Use of unrestrained, single-chamber barometric plethysmography to evaluate sensitivity to cholinergic stimulation in mouse models of allergic airway disease. J Allergy Clin Immunol 121 (2008) 334-335
31. Holmes B.J., MacAry P.A., Noble A., and Kemeny D.M. Antigen-specific CD8+ T cells inhibit IgE responses and interleukin-4 production by CD4+ T cells. Eur J Immunol 27 (1997) 2657-2665
32. Renz H., Lack G., Saloga J., Schwinzer R., Bradley K., Loader J., et al. Inhibition of IgE production and normalization of airways responsiveness by sensitized CD8 T cells in a mouse model of allergen-induced sensitization. J Immunol 152 (1994) 351-360
33. Wells J.W., Cowled C.J., Giorgini A., Kemeny D.M., and Noble A. Regulation of allergic airway inflammation by class I-restricted allergen presentation and CD8 T-cell infiltration. J Allergy Clin Immunol 119 (2007) 226-234
34. Diebold S.S., Schulz O., Alexopoulou L., Leitner W.W., and Flavell R.A. Reis e Sousa C. Role of TLR3 in the immunogenicity of replicon plasmid-based vaccines. Gene Ther 16 (2009) 359-366